|
⚲
|
| Keyboard |
| Tri Locum Partners LP
✚
|
|
|---|---|
| CRD # | 309678 |
| SEC # | 801-119074 |
| CIK # | 0001826434 |
| AUM | 1,088.9 M (2026-04-06) |
| Employees | 8 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 332-232-7373 |
| Address | 287 Park Avenue South New York, NY 10010 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001826434 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Johnson & Johnson | 101.3 | ||
| Intuitive Surgical Inc | 70.6 | ||
| Thermo Fisher Scientific Inc | 65.1 | ||
| Ascendis Pharma A/S | 58.4 | ||
| Vertex Pharmaceuticals Inc / Ma | 57.7 | ||
| Lilly Eli & Co | 56.8 | ||
| Synta Pharmaceuticals Corp | 54.1 | ||
| Dexcom Inc | 43.8 | ||
| United Therapeutics Corp | 41.7 | ||
| Nuvalent Inc | 31.6 | ||
| Teva Pharmaceutical Industries Ltd | 30.8 | ||
| Jazz Pharmaceuticals Inc | 30.0 | ||
| Argenx SE | 23.1 | ||
| Tarsus Pharmaceuticals Inc | 17.7 | ||
| Magenta Therapeutics Inc | 12.2 | ||
| Axsome Therapeutics Inc | 10.5 | ||
| MIND Medicine Mindmed Inc | 7.0 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Tri Locum Healthcare CAV Master LP | [2020-11-13] | 37.6 M | 136.8 M |
| Filed 2020-09-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Tri Locum Healthcare Master Fund LP | [2020-11-13] | 127.8 M | |
| Filed 2020-09-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 699.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 1 | 389.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 1,088.9 |
| By Discretionary | ||
| Discretionary | 8 | 1,088.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 1,088.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 1,064.6 | |
| United States Persons | 24.4 | |
| Total | 8 | 1,088.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Campbell Congdon | Director | 179 | 28 | |
| Khalid Iton | Director | 109 | 22 | |
| Cav GP Ltd | Promoter | 102 | 20 | |
| Tri Locum Partners LP | Executive Officer | 2 | 2 | |
| Prashanth Jayaram | Executive Officer | 2 | 2 | |
| Tri Locum Healthcare GP LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001826434] | |
| SC 13G | [0001826434] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Tri Locum Partners LP | Praxis Precision Medicines Inc | [2023-04-27] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Comparable Firms | State | AUM |
|---|---|---|
|
Benchstone Capital Management LP
✚
|
NY | 1,107.6 M |
|
Kings Court Capital PTE Ltd
✚
|
1,106.4 M | |
|
Deccan Value Investors LP
✚
|
1,105.9 M | |
|
TOBAM SAS
✚
|
1,086.2 M | |
|
Maritime Capital LLC
✚
|
NY | 1,080.4 M |
|
Fort Baker Capital Management LP
✚
|
CA | 1,073.8 M |
|
ACK Asset Management LLC
✚
|
CT | 1,068.3 M |
|
Almitas Capital LLC
✚
|
CA | 1,067.7 M |
|
Pinnbrook Capital Management LP
✚
|
NY | 1,065.0 M |
|
Penso Advisors LLC
✚
|
NY | 1,061.8 M |